ImmunityBio, Inc. IBRX

BCG (Bacillus Calmette-Guérin) treatment is a highly effective form of immunotherapy used to treat early-stage, non-muscle invasive bladder cancer. It uses a weakened, live strain of the tuberculosis bacteria, which is delivered directly into the bladder to stimulate the immune system and attack remaining cancer cells.How It WorksIntravesical Delivery: The liquid drug is placed directly into your bladder through a catheter (a thin tube inserted through the urethra).Immune Stimulation: Once inside, the weakened bacteria provoke an inflammatory response, tricking your immune system into sending specialized white blood cells to the bladder to destroy any remaining cancer cells.

We should be up .50-1.00-1.50 today TFBS

I can't buy more 570,000 is 170,000 past my limit.

I wish I could go to bed tonight and wake up 2030 and see what I believe could easily happen $248 a share and my
570000x248=141,360,000 million

At 68 I don't want those 4 years asleep to affect my life span however :)

Wow wow wow I missed the bad news?

Sickening

This makes zero sense. How will this action affect the share price in 1-3 years or 5 :) lmao not at all

WTF this is BS fuck hedge funds Wall Street MSM and BP

Where will the IBRX share price be in 3-5 years?

The world is so impatient now it operates in nanoseconds milliseconds seconds minutes and hours sometimes a few days.

Buy some shares and ride this to $300 plus in 5 years

Thanks Paul Silberberg you write the only posts worth reading

Don't buy calls why attach a time line to Share Price. Just buy shares and sit back and let it play out. Greed and leverage attached to time is not smart.

Ok OMG people

Dr.PSS had some type of meeting with FDA at AUA meeting in DC today Monday. Subject who knows that would be speculation. From his presentation I think he is trying to wake the idiots up that papillary or cis bladder cancer is the same pathology.

Sit back papillary approval is coming soon and it may state that Anktiva BCG is approved for all bladder cancer.